Phase
Condition
Depression
Treatment
Esketamine group
Racemic ketamine
Clinical Study ID
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Adult with treatment-resistant depression (TRD: not responded adequately to at leasttwo different antidepressants of adequate dose and duration) who has a currentdepressive episode (DSM 5)
Assessed and attested by clinic psychiatrist as appropriate to receive eitherracemic ketamine or Spravato® ketamine treatment for TRD
Aged ≥18 years
Written informed consent for research study obtained
Exclusion
Exclusion Criteria:
Not able to give informed consent
Any physical or mental condition which, in the opinion of the investigator, couldinterfere with study participation including outcome assessments
Patients who require an interpreter/translator for the clinic consent process, dueto the infeasibility of obtaining an interpreter for research assessments, includingself-rated scales
Study Design
Study Description
Connect with a study center
Royal Prince Alfred Hospital
Camperdown, New South Wales 2050
AustraliaActive - Recruiting
Black Dog Institute
Randwick, New South Wales 2031
AustraliaActive - Recruiting
Ramsay Clinic Northside
St Leonards, New South Wales 2065
AustraliaActive - Recruiting
Ramsay Clinic Lakeside
Warners Bay, New South Wales 2282
AustraliaActive - Recruiting
Gold Coast University Hospital
Southport, Queensland 4215
AustraliaActive - Recruiting
Ramsay Clinic Albert Road
Melbourne, Victoria 3004
AustraliaActive - Recruiting
Royal Melbourne Hospital
Parkville, Victoria 3052
AustraliaSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.